Ashwagandha vs Fish Oil / Omega-3
Both are commonly discussed for immune health. Ashwagandha and Fish Oil / Omega-3 both have moderate evidence — Ashwagandha edges ahead on research volume (20 vs 20 studies referenced).
Evidence last reviewed May 2026
Ashwagandha
Adaptogen
Fish Oil / Omega-3
Essential Fatty Acid
Evidence
🟡Moderate Evidence
🟡Moderate Evidence
Research says
Research agrees
Partially supported
Expert mentions
356
3 recommend
181
4 recommend
Studies
20
referenced
20
referenced
Study dose
300–600mg
The majority of positive RCTs and the meta-analytic evidence supporting stress and anxiety reduction used standardized extracts (e.g., KSM-66 or Sensoril) in the range of 300–600 mg per day, administered as a single dose or split across two doses; higher withanolide standardization (≥5%) is associated with the studied effects.
1000–4000mg
Studies across the reviewed literature examined doses ranging from approximately 1,000 mg to 4,000 mg of combined EPA+DHA per day; expert commentary (Huberman) highlights doses above 1 g EPA/day for mood effects and 2–4 g/day for triglyceride reduction, though optimal doses vary by condition and individual.
Best timing
MorningEveningWith food
MorningWith food
Who recommends
Caution
Generally safe
Generally safe
Ashwagandha
Key findings
- ·Multiple RCTs and at least one meta-analysis support statistically significant reductions in perceived stress and anxiety with ashwagandha supplementation, making this the best-evidenced use case.
- ·Cortisol reduction has been reported across several placebo-controlled trials, suggesting a plausible biological mechanism underlying the stress-relief effects.
- ·Doses of 300–600 mg per day of standardized extract, consistent with those used in positive clinical trials, are referenced across the reviewed literature as the studied therapeutic range.
Evidence gaps
- ·Long-term safety data beyond 12 weeks is largely absent, leaving the risk profile for extended supplementation — including liver health — poorly characterized.
- ·Most trials use proprietary or specific extract formulations, making it unclear whether findings generalize to the wide variety of ashwagandha products available to consumers.
Fish Oil / Omega-3
Key findings
- ·Multiple strong-quality meta-analyses and systematic reviews suggest fish oil supplementation may improve blood lipid profiles (particularly triglycerides) in people with hyperlipidemia, and may reduce arterial stiffness based on randomized controlled trial data.
- ·Omega-3 supplementation has been investigated for PCOS, with systematic reviews and umbrella reviews of meta-analyses examining effects on metabolic and endocrine outcomes, though the strength and consistency of benefit varies across endpoints.
- ·A Mediterranean-style dietary intervention supplemented with fish oil showed promising signals for mental health improvement in people with depression, though this was a single moderate-quality RCT and conclusions should be drawn cautiously.
Evidence gaps
- ·Most individual studies in this set do not report specific population characteristics or sample sizes in the available metadata, making it difficult to determine which populations benefit most and whether findings generalize broadly.
- ·The majority of expert claims assessed (135 out of 169) were rated as having insufficient evidence, suggesting that many specific claims made about fish oil — including highly specific therapeutic applications — outpace what the current research can confidently support.